Zomato CEO Deepinder Goyal, an Indian tech entrepreneur, has invested US$25 million from his own wealth to advance his business. He invested in ‘Continue Research’, a research-driven project concentrating on human-health monitoring, preventative care, and ageing.
Founder of food-delivery behemoth Zomato and its parent company Eternal Foodworks Limited, Deepinder Goyal
Goyal intends, under the new grant, to support scientists, nascent firms, and entrepreneurial teams all around researching methods to decelerate, halt, or even reverse biological ageing, while developing next-generation health-tracking instruments. Zomato ceo deepinder goyal stated in a post, “We think biology could be much simpler than we’ve made it.” ‘Continue Research’ has positioned itself during the last two years not as a typical startup seeking market exit but as a long-term research engine with one goal to improve people’s quality of life and longevity. Its purview spans biometrics, mental-wellness technologies
Zomato ceo deepinder goyal stressed in his public remarks that the goal is ambitious: enabling a “general population lifespan of 180+ years for actual change to take place”. He characterized the current moment as the “tail-end of the study on this hypothesis,” implying that breakthroughs could be only around the corner. The promised finance changes ‘Continue Research’ on a worldwide seed-backer for the long-lasting space show. Goyal believes that human health, ageing, and the next major tech frontier lay preventative science instead of just consumer internet.
READ ALSO: Heidi Health Secures $65M Series B Led by Point72 to Scale AI for Clinicians
Although his main emphasis is still on running Zomato
